Literature DB >> 19196661

Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.

Aaron F Carlin1, Satoshi Uchiyama, Yung-Chi Chang, Amanda L Lewis, Victor Nizet, Ajit Varki.   

Abstract

Human neutrophil Siglec-9 is a lectin that recognizes sialic acids (Sias) via an amino-terminal V-set Ig domain and possesses tyrosine-based inhibitory motifs in its cytoplasmic tail. We hypothesized that Siglec-9 recognizes host Sias as "self," including in cis interactions with Sias on the neutrophil's own surface, thereby dampening unwanted neutrophil reactivity. Here we show that neutrophils presented with immobilized multimerized Siaalpha2-3Galbeta1-4GlcNAc units engage them in trans via Siglec-9. The sialylated capsular polysaccharide of group B Streptococcus (GBS) also presents terminal Siaalpha2-3Galbeta1-4GlcNAc units, and similarly engages neutrophil Siglec-9, dampening neutrophil responses in a Sia- and Siglec-9-dependent manner. Reduction in the neutrophil oxidative burst, diminished formation of neutrophil extracellular DNA traps, and increased bacterial survival are also facilitated by GBS sialylated capsular polysaccharide interactions with Siglec-9. Thus, GBS can impair neutrophil defense functions by coopting a host inhibitory receptor via sialoglycan molecular mimicry, a novel mechanism of bacterial immune evasion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19196661      PMCID: PMC2665898          DOI: 10.1182/blood-2008-11-187302

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  Molecular cloning of MIS, a myeloid inhibitory siglec, that binds protein-tyrosine phosphatases SHP-1 and SHP-2.

Authors:  T Ulyanova; D D Shah; M L Thomas
Journal:  J Biol Chem       Date:  2001-01-29       Impact factor: 5.157

2.  Neutrophil extracellular traps kill bacteria.

Authors:  Volker Brinkmann; Ulrike Reichard; Christian Goosmann; Beatrix Fauler; Yvonne Uhlemann; David S Weiss; Yvette Weinrauch; Arturo Zychlinsky
Journal:  Science       Date:  2004-03-05       Impact factor: 47.728

3.  Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: engagement of CD33 induces apoptosis of leukemic cells.

Authors:  C Vitale; C Romagnani; A Puccetti; D Olive; R Costello; L Chiossone; A Pitto; A Bacigalupo; L Moretta; M C Mingari
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

4.  Cryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activation.

Authors:  N Razi; A Varki
Journal:  Glycobiology       Date:  1999-11       Impact factor: 4.313

5.  Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.

Authors:  M R Wessels; L C Paoletti; D L Kasper; J L DiFabio; F Michon; K Holme; H J Jennings
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

6.  Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2.

Authors:  S P Paul; L S Taylor; E K Stansbury; D W McVicar
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

7.  Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis.

Authors:  Esra Nutku; Hideyuki Aizawa; Sherry A Hudson; Bruce S Bochner
Journal:  Blood       Date:  2003-02-27       Impact factor: 22.113

8.  Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.

Authors:  Yuzuru Ikehara; Sanae Kabata Ikehara; James C Paulson
Journal:  J Biol Chem       Date:  2004-08-03       Impact factor: 5.157

9.  Discovery and characterization of sialic acid O-acetylation in group B Streptococcus.

Authors:  Amanda L Lewis; Victor Nizet; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

10.  The inhibitory effect of anti-CD33 monoclonal antibodies on AML cell growth correlates with Syk and/or ZAP-70 expression.

Authors:  Larisa Balaian; Rui-kun Zhong; Edward D Ball
Journal:  Exp Hematol       Date:  2003-05       Impact factor: 3.084

View more
  178 in total

1.  Specific inactivation of two immunomodulatory SIGLEC genes during human evolution.

Authors:  Xiaoxia Wang; Nivedita Mitra; Ismael Secundino; Kalyan Banda; Pedro Cruz; Vered Padler-Karavani; Andrea Verhagen; Chris Reid; Martina Lari; Ermanno Rizzi; Carlotta Balsamo; Giorgio Corti; Gianluca De Bellis; Laura Longo; William Beggs; David Caramelli; Sarah A Tishkoff; Toshiyuki Hayakawa; Eric D Green; James C Mullikin; Victor Nizet; Jack Bui; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

2.  Sialylation of lipooligosaccharides is dispensable for the virulence of Haemophilus ducreyi in humans.

Authors:  Stanley M Spinola; Wei Li; Kate R Fortney; Diane M Janowicz; Beth Zwickl; Barry P Katz; Robert S Munson
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

Review 3.  Multifarious roles of sialic acids in immunity.

Authors:  Ajit Varki; Pascal Gagneux
Journal:  Ann N Y Acad Sci       Date:  2012-04       Impact factor: 5.691

Review 4.  Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?

Authors:  Huan Cao; Paul R Crocker
Journal:  Immunology       Date:  2010-11-11       Impact factor: 7.397

5.  CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells.

Authors:  Mary K O'Reilly; Hua Tian; James C Paulson
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

6.  Inhibitory receptor expression on neonatal immune cells.

Authors:  J Walk; G H A Westerlaken; N O van Uden; M E Belderbos; L Meyaard; L J Bont
Journal:  Clin Exp Immunol       Date:  2012-08       Impact factor: 4.330

7.  Post-conversion sialylation of prions in lymphoid tissues.

Authors:  Saurabh Srivastava; Natallia Makarava; Elizaveta Katorcha; Regina Savtchenko; Reinhard Brossmer; Ilia V Baskakov
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

8.  CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases : English version.

Authors:  T Tsubata
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

Review 9.  [CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases. German version].

Authors:  T Tsubata
Journal:  Z Rheumatol       Date:  2016-02       Impact factor: 1.372

Review 10.  Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies.

Authors:  Jay Vornhagen; Kristina M Adams Waldorf; Lakshmi Rajagopal
Journal:  Trends Microbiol       Date:  2017-06-17       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.